stem cell-derived cardiomyocyte therapy (ES Cell International)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestem cell-derived cardiomyocyte therapy (ES Cell International)
Drug Alias Namehuman embryonic stem cell therapy (ES Cell International)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesESI BIO
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesESI BIO
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A